Your browser doesn't support javascript.
loading
Cost-effectiveness of denosumab versus zoledronic acid for preventing skeletal-related events in the Czech Republic.
Cristino, Joaquim; Finek, Jíndrich; Jandova, Petra; Kolek, Martin; Pásztor, Bálint; Giannopoulou, Christina; Qian, Yi; Brezina, Tomas; Lothgren, Mickael.
Affiliation
  • Cristino J; a Amgen (Europe) GmbH , Zug , Switzerland.
  • Finek J; b Pilsen Faculty Hospital, Clinic of Oncology and Radiotherapy (FN v Plzni) , Pilsen , Czech Republic.
  • Jandova P; c Amgen s.r.o. , Prague , Czech Republic.
  • Kolek M; d Oaks Consulting , Prague , Czech Republic.
  • Pásztor B; d Oaks Consulting , Prague , Czech Republic.
  • Giannopoulou C; a Amgen (Europe) GmbH , Zug , Switzerland.
  • Qian Y; e Amgen Inc. , Thousand Oaks , CA , USA.
  • Brezina T; c Amgen s.r.o. , Prague , Czech Republic.
  • Lothgren M; a Amgen (Europe) GmbH , Zug , Switzerland.
J Med Econ ; 20(8): 799-812, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28485692

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Diseases / Diphosphonates / Bone Density Conservation Agents / Denosumab / Imidazoles / Neoplasms Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2017 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Diseases / Diphosphonates / Bone Density Conservation Agents / Denosumab / Imidazoles / Neoplasms Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2017 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom